Coleman, David T <br/><br/>
Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.  [electronic resource] 

 -  Oncotarget  May 2016 
 - 32200-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.8609  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Calcium Signaling--drug effects<br/>Cancer-Associated Fibroblasts--drug effects<br/>Cardiac Glycosides--pharmacology<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>Cell Shape--drug effects<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Repositioning<br/>Fibronectins--metabolism<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Male<br/>Myofibroblasts--drug effects<br/>Promoter Regions, Genetic<br/>Prostatic Neoplasms--drug therapy<br/>Smad Proteins--genetics<br/>Small Molecule Libraries<br/>Sodium-Potassium-Exchanging ATPase--antagonists & inhibitors<br/>Transfection<br/>Transforming Growth Factor beta--pharmacology<br/>Tumor Microenvironment